Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001053452 | SCV001217712 | uncertain significance | not provided | 2022-10-13 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 598 of the ABCA4 protein (p.Val598Met). This variant is present in population databases (rs201838557, gnomAD 0.02%). This missense change has been observed in individual(s) with retinitis pigementosa or Stargardt disease (PMID: 20647261, 29555955, 32619608). ClinVar contains an entry for this variant (Variation ID: 849480). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ABCA4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002481977 | SCV002792478 | uncertain significance | Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 | 2022-03-03 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004813627 | SCV005073010 | uncertain significance | Retinal dystrophy | 2022-01-01 | criteria provided, single submitter | clinical testing |